Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
8.38
-0.17 (-1.99%)
At close: Mar 17, 2026, 4:00 PM EDT
8.73
+0.35 (4.20%)
After-hours: Mar 17, 2026, 7:49 PM EDT
Karyopharm Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$17.50
Upside
+108.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +234.13% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +79.00% | Feb 18, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $30 → $19 | Buy | Maintains | $30 → $19 | +126.73% | Nov 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $15 | Hold → Strong Buy | Upgrades | $15 | +79.00% | Oct 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $15 → $12 | Buy | Reiterates | $15 → $12 | +43.20% | Oct 9, 2025 |
| Baird | Baird | Buy Maintains $25 → $21 | Buy | Maintains | $25 → $21 | +150.60% | Oct 9, 2025 |
| Baird | Baird | Buy Maintains $42 → $25 | Buy | Maintains | $42 → $25 | +198.33% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +222.20% | Jul 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $34 → $33 | Buy | Maintains | $34 → $33 | +293.79% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $10 | Buy | Maintains | $5 → $10 | +19.33% | May 13, 2025 |
| Baird | Baird | Buy Maintains $54 → $42 | Buy | Maintains | $54 → $42 | +401.19% | May 13, 2025 |
| Baird | Baird | Buy Maintains $75 → $54 | Buy | Maintains | $75 → $54 | +544.39% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $56 | Strong Buy | Maintains | $7 → $56 | +568.26% | Feb 26, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $45 | Buy | Reiterates | $45 | +436.99% | Feb 20, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.